Cargando…

Impacto de los días transcurridos desde el inicio de los síntomas hasta la hospitalización en la mortalidad hospitalaria por COVID-19: el tiempo importa

BACKGROUND: COVID-19 shows different clinical and pathophysiological stages over time. Theeffect of days elapsed from the onset of symptoms (DEOS) to hospitalization on COVID-19prognostic factors remains uncertain. We analyzed the impact on mortality of DEOS to hospital-ization and how other indepen...

Descripción completa

Detalles Bibliográficos
Autores principales: Maestro de la Calle, G., García Reyne, A., Lora-Tamayo, J., Muiño Miguez, A., Arnalich-Fernandez, F., Beato Pérez, J.L., Vargas Núñez, J.A., Caudevilla Martínez, M.A., Alcalá Rivera, N., Orviz Garcia, E., Sánchez Moreno, B., Freire Castro, S.J., Rhyman, N., Pesqueira Fontan, P.M., Piles, L., López Caleya, J.F., Fraile Villarejo, M.E., Jiménez-García, N., Boixeda, R., González Noya, A., Gracia Gutiérrez, A., Martín Oterino, J.Á., Gómez Huelgas, R., Antón Santos, J.M., Lumbreras Bermejo, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073578/
https://www.ncbi.nlm.nih.gov/pubmed/37125001
http://dx.doi.org/10.1016/j.rce.2023.02.006
Descripción
Sumario:BACKGROUND: COVID-19 shows different clinical and pathophysiological stages over time. Theeffect of days elapsed from the onset of symptoms (DEOS) to hospitalization on COVID-19prognostic factors remains uncertain. We analyzed the impact on mortality of DEOS to hospital-ization and how other independent prognostic factors perform when taking this time elapsedinto account. METHODS: This retrospective, nationwide cohort study, included patients with confirmed COVID-19 from February 20th and May 6th, 2020. The data was collected in a standardized online datacapture registry. Univariate and multivariate COX-regression were performed in the generalcohort and the final multivariate model was subjected to a sensitivity analysis in an earlypresenting (EP; < 5 DEOS) and late presenting (LP; ≥5 DEOS) group. RESULTS: 7915 COVID-19 patients were included in the analysis, 2324 in the EP and 5591 in theLP group. DEOS to hospitalization was an independent prognostic factor of in-hospital mortalityin the multivariate Cox regression model along with other 9 variables. Each DEOS incrementaccounted for a 4.3% mortality risk reduction (HR 0.957; 95% CI 0.93---0.98). Regarding variationsin other mortality predictors in the sensitivity analysis, the Charlson Comorbidity Index onlyremained significant in the EP group while D-dimer only remained significant in the LP group. CONCLUSION: When caring for COVID-19 patients, DEOS to hospitalization should be consideredas their need for early hospitalization confers a higher risk of mortality. Different prognosticfactors vary over time and should be studied within a fixed timeframe of the disease.